4.5 Article

Pulmonary outcome and its correlates in school-aged children born with a gestational age ≤ 32 weeks

Journal

RESPIRATORY MEDICINE
Volume 107, Issue 12, Pages 1966-1976

Publisher

W B SAUNDERS CO LTD
DOI: 10.1016/j.rmed.2013.06.020

Keywords

Premature birth; Bronchopulmonary dysplasia; Mid term outcome; Lung function tests; Children

Funding

  1. Bordeaux University Hospital [DGS 2006/0380]

Ask authors/readers for more resources

Background: There is limited data regarding factors influencing the respiratory outcome at school age of ex-preterms born since the introduction of antenatal steroids, surfactant replacement together with less aggressive ventilation. Objectives: To establish the main antenatal, neonatal and early childhood respiratory correlates of respiratory status in school-aged children born at <= 32weeks of gestation. Methods: Ex-preterm children born at <= 32weeks of gestation between 1997 and 2001 at Bordeaux University Hospital were evaluated at school age, using a respiratory questionnaire and lung function tests (spirometry, plethysmography, exercise challenge test and CO lung diffusing capacity DLCO measurements). Factors associated with lung function were investigated using polynomial regression analyses. Results: Of the 151 included children [mean age: 8.6 +/- 0.8 years; mean gestational age, 30.1 +/- 1.7 weeks; mean birth weight = 1310 +/- 380 g; 68.2% ventilated at birth; 46.4% treated with surfactant; 36.4% with prior bronchopulmonary dysplasia (BPD)], 47% presented obstructive lung abnormalities, 11% restrictive or mixed lung abnormalities, 41% exercise-induced bronchoconstriction, and 15.5% reduced DLCO. Surfactant therapy was independently associated with a lower risk of lung abnormalities (p < 0.05). The association between BPD and lung abnormalities at school age was not significant, but prior BPD increased the risk of restrictive or mixed abnormalities (odds ratio: 6.11, confidence interval [1.1; 33.99]). Early childhood respiratory events were not associated with the occurrence of lung abnormalities. Conclusion: Children born at <= 32 weeks of gestation remain at risk for impaired lung function at school age in particular when they did not receive surfactant. Restrictive or mixed lung defects are mainly associated with prior BPD. (C) 2013 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Pediatrics

Cystic fibrosis and noninvasive liver fibrosis assessment methods in children

Raphael Enaud, Eric Frison, Sophie Missonnier, Aude Fischer, Victor de Ledinghen, Paul Perez, Stephanie Bui, Michael Fayon, Jean-Francois Chateil, Thierry Lamireau

Summary: This study evaluated the repeatability and reproducibility of TE and pSWE VTQ in children with CF, finding both techniques to be reliable for assessing liver fibrosis. The high ICC values obtained suggest that TE and pSWE VTQ can be used effectively in the follow-up of CF patients, depending on their availability in CF centers.

PEDIATRIC RESEARCH (2022)

Review Pharmacology & Pharmacy

In utero exposure to antiretroviral drugs and pregnancy outcomes: Analysis of the French ANRS pharmacovigilance database

Laura Saint-Lary, Alpha Diallo, Laure-Amelie de Monteynard, Christelle Paul, Lucie Marchand, Roland Tubiana, Josiane Warszawski, Laurent Mandelbrot, Claire Rekacewicz, Ventzislava Petrov-Sanchez, Albert Faye, Jeanne Sibiude, Francois Dabis, Agnes Sommet, Valeriane Leroy

Summary: The study found that the use of protease inhibitor (PI) and non-nucleoside reverse transcriptase inhibitor (NNRTI) based regimens did not show significant association with adverse pregnancy outcomes, except for nucleoside reverse transcriptase inhibitor (NRTI) combinations. The number of integrase inhibitor (INI)-based combinations was too low to draw conclusions from.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2022)

Article Respiratory System

Inflammation biomarkers in sputum for clinical trials in cystic fibrosis: current understanding and gaps in knowledge

Agathe Lepissier, Charlotte Addy, Kate Hayes, Sabrina Noel, Stephanie Bui, Pierre-Regis Burgel, Lieven Dupont, Olaf Eickmeier, Michael Fayon, Teresinha Leal, Carlos Lopes, Damian G. Downey, Isabelle Sermet-Gaudelus

Summary: This study aimed to evaluate the clinical reliability, validity, and clinical relevance of sputum biomarkers in cystic fibrosis. The results showed that sputum biomarkers have potential as outcome measures in clinical trials, but further research is needed to standardize processing and validate the reliability and validity of these biomarkers.

JOURNAL OF CYSTIC FIBROSIS (2022)

Article Immunology

Growth and CD4 patterns of adolescents living with perinatally acquired HIV worldwide, a CIPHER cohort collaboration analysis

Julie Jesson, Siobhan Crichton, Matteo Quartagno, Marcel Yotebieng, Elaine J. Abrams, Kulkanya Chokephaibulkit, Sophie Le Coeur, Marie-Helene Ake-Assi, Kunjal Patel, Jorge Pinto, Mary Paul, Rachel Vreeman, Mary-Ann Davies, Jihane Ben-Farhat, Russell Van Dyke, Ali Judd, Lynne Mofenson, Marissa Vicari, George Seage, Linda-Gail Bekker, Shaffiq Essajee, Diana Gibb, Martina Penazzato, Intira Jeannie Collins, Kara Wools-Kaloustian, Amy Slogrove, Kate Powis, Paige Williams, Mogomotsi Matshaba, Lineo Thahane, Phoebe Nyasulu, Bhekumusa Lukhele, Lumumba Mwita, Adeodata Kekitiinwa-Rukyalekere, Sebastian Wanless, Tessa Goetghebuer, Claire Thorne, Josiane Warszawski, Luisa Galli, Annemarie M. C. van Rossum, Carlo Giaquinto, Magdalena Marczynska, Laura Marques, Filipa Prata, Luminita Ene, Lyuba Okhonskaya, Marisa Navarro, Antoinette Frick, Lars Naver, Christian Kahlert, Alla Volokha, Elizabeth Chappell, Jean William Pape, Vanessa Rouzier, Adias Marcelin, Regina Succi, Annette H. Sohn, Azar Kariminia, Andrew Edmonds, Patricia Lelo, Rita Lyamuya, Edith Apondi Ogalo, Francesca Akoth Odhiambo, Andreas D. Haas, Carolyn Bolton, Josephine Muhairwe, Hannock Tweya, Mariam Sylla, Marceline D'Almeida, Lorna Renner, Mark J. Abzug, James Oleske, Murli Purswani, Chloe Teasdale, Harriet Nuwagaba-Biribonwoha, Ruth Goodall, Valeriane Leroy

Summary: Adolescents living with HIV face various co-morbidities, including growth retardation and immunodeficiency. This study analyzed data from CIPHER global project and found that growth patterns differed by sex and region, while CD4 patterns were similar. Early diagnosis and timely treatment are crucial for improving growth and CD4 outcomes in adolescents with HIV.

JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2022)

Article Pediatrics

Prevalence and Determinants of Wheezing and Bronchodilatation in Children With Cystic Fibrosis: A Retrospective Cohort Study

Francois Galode, O. Ladipo, A. Andrieux, H. Feghali, S. Bui, Michael Fayon

Summary: The study found that wheezing and a positive bronchodilatory response are common in children with CF, with wheezing potentially impacting lung function negatively. Predictive markers of wheezing and differences in respiratory function affect bronchodilatory responses in children of different age groups.

FRONTIERS IN PEDIATRICS (2022)

Article Pediatrics

Effectiveness and Safety of Atazanavir Use for the Treatment of Children and Adolescents Living With HIV: A Systematic Review

Laura Saint-Lary, Marc Harris Dassi Tchoupa Revegue, Julie Jesson, Francoise Renaud, Martina Penazzato, Claire L. Townsend, John O'Rourke, Valeriane Leroy

Summary: This study systematically reviewed the safety and effectiveness of atazanavir use in children and adolescents. The results showed that there were limited data on the safety and effectiveness of atazanavir in this population, with transient grade 3-4 hyperbilirubinemia being the main adverse outcome reported. However, atazanavir/ritonavir remains a suitable option for a preferred second-line antiretroviral regimen in children and adolescents.

FRONTIERS IN PEDIATRICS (2022)

Review Obstetrics & Gynecology

Adverse perinatal outcomes associated with prenatal exposure to protease-inhibitor-based versus non-nucleoside reverse transcriptase inhibitor-based antiretroviral combinations in pregnant women with HIV infection: a systematic review and meta-analysis

Laura Saint-Lary, Justine Benevent, Christine Damase-Michel, Christophe Vayssiere, Valeriane Leroy, Agnes Sommet

Summary: In this study, the researchers conducted a systematic review on the adverse perinatal outcomes associated with prenatal exposure to protease inhibitors (PI) based antiretroviral therapy (ART) compared with non-nucleoside reverse transcriptase inhibitors (NNRTI) based ART. The findings showed no significant association between prenatal exposure to PIs and most adverse perinatal outcomes, except for a significantly increased risk of very small for gestational age (VSGA).

BMC PREGNANCY AND CHILDBIRTH (2023)

Article Immunology

Cost-effectiveness of broadly neutralizing antibody prophylaxis for HIV-exposed infants in sub-Saharan African settings

Caitlin M. Dugdale, Ogochukwu Ufio, Christopher Alba, Sallie R. Permar, Lynda Stranix-Chibanda, Coleen K. Cunningham, Genevieve G. Fouda, Landon Myer, Milton C. Weinstein, Valeriane Leroy, Elizabeth J. McFarland, Kenneth A. Freedberg, Andrea L. Ciaranello

Summary: Infant HIV prophylaxis with broadly neutralizing anti-HIV antibodies (bNAbs) could be a cost-effective intervention to reduce vertical HIV transmission in sub-Saharan African settings, according to a cost-effectiveness analysis. The study estimated the potential clinical impact and cost-effectiveness of hypothetical bNAb prophylaxis programs for HIV-exposed children in Cote d'Ivoire, South Africa, and Zimbabwe and found that bNAb prophylaxis would significantly reduce infant HIV incidence.

JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2023)

Article Immunology

Global variations in pubertal growth spurts in adolescents living with perinatal HIV

Siobhan Crichton, Julie Jesson, Marie-Helene Ake-Assi, Erik Belfrage, Mary-Ann Davies, Jorge Pinto, Chloe Teasdale, Nguyen Van Lam, Rachel Vreeman, Mary Paul, Paige William, Marcel Yotebieng, Valeriane Leroy, Ruth Goodall, Elaine Abrams, Russell Van Dyke, Ali Judd, Marissa Vicari, Intira Jeannie Collins, Kara Wools-Kaloustian, Kunjal Patel, Amy Slogrove, Kathleen M. Powis, Mogomotsi Matshaba, Lineo Thahane, Phoebe Nyasulu, Bhekumusa Lukhele, Lumumba Mwita, Adeodata Kekitiinwa-Rukyalekere, Tessa Goetghebuer, Claire Thorne, Josiane Warszawski, Elena Chiappini, Annemarie van Rossum, Magdalena Marczynska, Laura Marques, Filipa Prata, Luminita Ene, Liubov Okhonskaya, Marisa Navarro, Maria Mendez, Paolo Paioni, Sophie Le Coeur, Alla Volokha, Jean William Pape, Vanessa Rouzier, Adias Marcelin, Kulkanya Chokephaibulkit, Annette H. Sohn, Azar Kariminia, Andrew Edmonds, Patricia Lelo, Francesca Akoth Odhiambo, Andreas D. Haas, Carolyn Bolton, Mariam Sylla, Lehila Bagnan Tossa, Lorna Renner, Mark J. Abzug, James Oleske, Murli Purswani, Elaine Chadwick

Summary: This study aimed to describe pubertal growth spurts among adolescents with perinatally acquired HIV on antiretroviral therapy. The study found that older age at ART initiation and lower height-for-age z-scores were associated with delayed and less intense growth spurts. Longer-term follow-up is important for understanding the impact of delayed growth.
Review Immunology

Effectiveness and safety of tenofovir alafenamide in children and adolescents living with HIV: a systematic review

John O'Rourke, Claire L. Townsend, Edith Milanzi, Intira Jeannie Collins, Hannah Castro, Ali Judd, Marissa Vicari, Julie Jesson, Valeriane Leroy, Martina Penazzato, Francoise Renaud

Summary: This systematic review assessed the efficacy and safety of TAF in infants, children, and adolescents living with HIV. The results showed that TAF-containing regimens can effectively suppress viral replication and have good safety profiles over 24-48 weeks of treatment. However, further research is needed to evaluate the long-term efficacy and safety, including the impact on weight and metabolic changes, in children and adolescents.

JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2023)

Article Medicine, General & Internal

Global HIV prevention, care and treatment services for children: a cross-sectional survey from the International Epidemiology Databases to Evaluate AIDS (IeDEA) consortium

Rachel C. Vreeman, Constantin T. Yiannoutsos, Nik Khairulddin Nik Yusoff, C. William Wester, Andrew Edmonds, Susan Ofner, Mary-Ann Davies, Valeriane Leroy, Pagakrong Lumbiganon, Regina Celia de Menezes Succi, Christella Twizere, Steven Brown, Carolyn Bolton-Moore, Ounoo Elom Takassi, Michael Scanlon, Roxanne Martin, Kara Wools-Kaloustian, IeDEA

Summary: This study aims to assess the access children with HIV have to comprehensive HIV care services, evaluate the implementation and scale-up of services, and explore whether access to these services influences retention in care. A cross-sectional survey was conducted in 174 IeDEA sites in 32 countries, and a comprehensiveness score based on WHO's essential services was developed to categorize sites. The findings suggest that meeting recommendations for comprehensive HIV services should remain a global priority.

BMJ OPEN (2023)

Article Hematology

Potential for a large-scale newborn screening strategy for sickle cell disease in Mali: A comparative diagnostic performance study of two rapid diagnostic tests (SickleScan® and HemotypeSC®) on cord blood

Aldiouma Guindo, Zenab Cisse, Ibrahima Keita, Sophie Desmonde, Yeya dit Sadio Sarro, Boubacari A. Toure, Mohamed Ag Baraika, Oumarou Tessougue, Pierre Guindo, Moussa Coulibaly, Oumar Traore, Niagale Sylla, Mahamadou Diassana, Amaguire Saye, Valentina Picot, Emilie Lauressergues, Valeriane Leroy

Summary: This study assessed the acceptability and diagnostic performances of two rapid diagnostic tests for sickle cell disease (SCD) newborn screening in Mali. The results showed that both tests had reliable diagnostic performances to exclude SCD-free newborns and identify SCD carriers. The study suggests that this strategy could be implemented in large-scale newborn screening programs.

BRITISH JOURNAL OF HAEMATOLOGY (2023)

Article Public, Environmental & Occupational Health

Integration of HIV care into maternal and child health services in the global IeDEA consortium

John Humphrey, Elizabeth Nagel, James G. Carlucci, Andrew Edmonds, Aarti Kinikar, Kim Anderson, Valeriane Leroy, Daisy Machado, Dwight E. Yin, Marco Tulio Luque, Madeleine Amorissani-Folquet, Safari Mbewe, Tulathip Suwanlerk, Athanase Munyaneza, Rena C. Patel, Beverly Musick, Lisa Abuogi, Kara Wools-Kaloustian

Summary: The WHO recommends integrating HIV services with maternal and child health services to improve care for women living with HIV and their children. A survey of 202 HIV treatment sites in 40 countries found varying levels of integration, with higher proportions in Southern and East Africa. Further research is needed to understand the impact of integration on maternal and child health outcomes.

FRONTIERS IN GLOBAL WOMENS HEALTH (2023)

Meeting Abstract Immunology

Cost-effectiveness of broadly neutralizing antibodies for HIV prophylaxis for all infants born in high-burden settings

C. Alba, S. Malhotra, S. Horsfall, M. Barnhart, K. Chapman, C. K. Cunningham, P. Fast, G. G. Fouda, K. A. Freedberg, L. Ghazaryan, V. Leroy, C. Mann, M. M. McCluskey, E. J. McFarland, V. Muturi-Kioi, S. R. Permar, D. Sok, L. Stranix-Chibanda, M. C. Weinstein, A. L. Ciaranello, C. M. Dugdale

JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2022)

No Data Available